Russia Launches First Personalized Cancer Vaccine Trial
In what could signal a new era in cancer treatment, Russia has begun testing a personalized vaccine designed to train the body’s immune system to attack cancer cells specific to each patient. The first recipient, a 60-year-old man with stage three melanoma, received the experimental drug Neooncovac this week. Developed
